Showing results (211-220 of 342) with videos related to

Sort By:
Pageof 35
European Journal of Haematology|September 15, 2023
Long-term effectiveness of eculizumab: Data from the International PNH RegistryLouis Terriou, Jong Wook Lee, Cecily Forsyth, et al.
Blood Cells, Molecules & Diseases|May 20, 2014
Eliglustat, an investigational oral therapy for Gaucher disease type 1: Phase 2 trial results after 4 years of treatmentElena Lukina, Nora Watman, Marta Dragosky, et al.
Leukemia & Lymphoma|August 26, 2011
Allogeneic hematopoietic cell transplant for multiple myeloma using reduced intensity conditioning therapy, 1998-2006: factors associated with improved survival outcomeIan Nivison-Smith, Anthony J Dodds, Richard Doocey, et al.
European Journal of Haematology|May 3, 2018
Prognostic markers in core-binding factor AML and improved survival with multiple consolidation cycles of intermediate-/high-dose cytarabineAshvind Prabahran, Mark Tacey, Shaun Fleming, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004Ian Nivison-Smith, Kenneth F Bradstock, Anthony J Dodds, et al.
Orphanet Journal of Rare Diseases|April 22, 2015
Effect of cyclic, low dose pyrimethamine treatment in patients with Late Onset Tay Sachs: an open label, extended pilot studyEtty Osher, Aviva Fattal-Valevski, Liora Sagie, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 7, 2009
Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1Gregory A Grabowski, Katherine Kacena, J Alexander Cole, et al.
Internal Medicine Journal|December 22, 2021
Consensus guidelines for improving patients' understanding of invasive fungal disease and related risk prevention in the haematology/oncology setting, 2021Shevon S Fernando, Emma K Paige, Claire Dendle, et al.
Internal Medicine Journal|June 17, 2024
Clinical outcomes of chronic myeloid leukaemia patients taking asciminib through a Managed Access Programme (MAP) in AustraliaLynette Chee, Nora Lee, Andrew Grigg, et al.
American Journal of Hematology|April 2, 2024
A 10-year follow-up of high-dose ambroxol treatment combined with enzyme replacement therapy for neuropathic Gaucher diseaseSoojin Hwang, Hyunwoo Bae, Ji-Hee Yoon, et al.
Pageof 35